Ocular hypertension Trials in Largo, United States
Conditions / Ocular hypertension / Largo, United States
Ocular hypertension is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06394973 | Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension | COMPLETED | PHASE2 |
| NCT04630808 | MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension | COMPLETED | PHASE3 |
| NCT04405245 | Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma | COMPLETED | PHASE2 |
| NCT07082816 | Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction | COMPLETED | — |
| NCT07082816 | Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction | COMPLETED | — |
| NCT05913232 | Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension | COMPLETED | PHASE2 |
| NCT04742283 | Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension | COMPLETED | PHASE2 |
| NCT02179008 | Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension | COMPLETED | PHASE2 |
| NCT00800267 | A Study of Glaucoma or Ocular Hypertension in Patients Within the United States | COMPLETED | PHASE3 |
| NCT03808688 | Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting | COMPLETED | PHASE4 |